Ningbo Menovo Pharm Co Ltd (603538) — Strategic Asset Allocation Index
Ningbo Menovo Pharm Co Ltd (603538) has a Strategic Asset Allocation Index of 86.8% as of June 2023. Strategic assets (PP&E of CN¥1.90 Billion plus long-term investments of CN¥-) total CN¥1.90 Billion, measured against net assets of CN¥2.19 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 603538 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ningbo Menovo Pharm Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Ningbo Menovo Pharm Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 86.8%, representing strategic assets of CN¥1.90 Billion against net assets of CN¥2.19 Billion CNY. See Ningbo Menovo Pharm Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ningbo Menovo Pharm Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Ningbo Menovo Pharm Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Ningbo Menovo Pharm Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 81.6% | CN¥1.61 Billion | CN¥1.61 Billion | CN¥- | CN¥1.98 Billion | ▲ +15.6 pp |
| 2020 | 66.0% | CN¥1.16 Billion | CN¥1.16 Billion | CN¥- | CN¥1.76 Billion | ▲ +6.9 pp |
| 2019 | 59.1% | CN¥927.37 Million | CN¥927.37 Million | CN¥- | CN¥1.57 Billion | ▲ +4.0 pp |
| 2018 | 55.1% | CN¥738.76 Million | CN¥738.76 Million | CN¥- | CN¥1.34 Billion | ▲ +24.3 pp |
| 2017 | 30.9% | CN¥358.74 Million | CN¥358.74 Million | CN¥- | CN¥1.16 Billion | ▼ -8.8 pp |
| 2016 | 39.7% | CN¥290.21 Million | CN¥290.21 Million | CN¥- | CN¥731.02 Million | ▼ -0.6 pp |
| 2015 | 40.3% | CN¥260.40 Million | CN¥260.40 Million | CN¥- | CN¥645.81 Million | ▼ -5.7 pp |
| 2014 | 46.0% | CN¥259.56 Million | CN¥259.56 Million | CN¥- | CN¥564.34 Million | ▼ -35.6 pp |
| 2013 | 81.6% | CN¥397.60 Million | CN¥397.60 Million | CN¥- | CN¥487.44 Million | ▲ +3.9 pp |
| 2012 | 77.7% | CN¥343.79 Million | CN¥343.79 Million | CN¥- | CN¥442.58 Million | ▲ +4.9 pp |
| 2011 | 72.8% | CN¥275.39 Million | CN¥275.39 Million | CN¥- | CN¥378.47 Million | — |